Patient Leaflet Updated 31-May-2023 | Chiesi Limited
Natecal D3 Chewable Tablets
NATECAL D3
600 mg + 400 I.U. chewable tablet
calcium + cholecalciferol
1. What Natecal D3 is and what it is used for.
2. What you need to know before you take Natecal D3.
3. How to take Natecal D3.
4. Possible side effects.
5. How to store Natecal D3.
6. Contents of the pack and other information.
Natecal D3 chewable tablets contain two active substances, calcium carbonate and cholecalciferol (vitamin D3). Both calcium and vitamin D3 are found in the diet and vitamin D is also produced in the skin after exposure to the sun. Natecal D3 chewable tablets are used to treat and prevent vitamin D/calcium deficiency.
Natecal D3 is used:
Before taking this medicine you should first consult with your doctor or pharmacist to check if your vitamin D or calcium levels are too low or at risk of being too low.
Talk to your doctor or pharmacist before taking Natecal D3.
Tell your doctor or pharmacist if you are taking:
This medicinal product is likely to interact with some foods, for example those containing oxalic acid (like spinach, rhubarb, sorrel, cocoa, tea…), phosphate (e.g. ham, sausages, cheese spread…) or phytic acid (e.g. pulses, whole cereals, chocolate…). Therefore it is recommended to take Natecal D3 two hours before or after meals containing this kind of food.
Natecal D3 chewable tablets should only be used in pregnancy and breast-feeding when it has been recommended by a doctor or pharmacist.
This medicinal product contains: sorbitol (E420), aspartame (E951), lactose, hydrogenated soya oil, sucrose, saccharin sodium (E954), sodium croscarmellose (E468).
This medicinal product contains sorbitol. Sorbitol is a source of fructose. If your doctor has told you that you have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor or pharmacist before you take or receive this medicine.
This medicinal product contains 5 mg aspartame in each chewable tablet, which is equivalent to 0.007 mg/kg. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
This medicinal product contains lactose and sucrose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor or pharmacist before taking this medicine. Sucrose may be harmful to the teeth.
This medicinal product contains hydrogenated soya oil. If you are allergic to peanut or soya, do not use this medicinal product.
This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
Always take Natecal D3 exactly as your doctor or pharmacist has told you. You should check with your doctor or pharmacist if you are not sure.
The recommended dose for adults and elderly is one tablet twice a day (e.g. one in the morning and one in the evening) preferably after meals.
The tablets may be chewed or sucked, they must not be swallowed whole.
Contact your doctor. If you cannot do this, go to your nearest hospital accident and emergency (casualty) department, taking any remaining tablets and the packaging with you.
Take it as soon as you remember. Then take your next dose at the usual time. However, if it is almost time for your next dose, skip the missed dose and continue as usual. Never take two doses at the same time.
Like all medicines, Natecal D3 can cause side effects, although not everybody gets them.
The following effects are uncommon: (may affect up to 1 in 100 people)
The following effects are rare: (may affect up to 1 in 1,000 people)
Patients with kidney failure could have a potential risk of high levels of phosphate in the blood, kidney stones and too much calcium being deposited in the kidneys.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the YellowCard Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
This medicinal product is a chewable tablet.
The tablet has a round, bevelled edge shape and is white to almost white with the inscription “D” on one side.
Tablet container containing 12 or 60 tablets.
This leaflet was last revised in April 2023
PK82151 - CP0020/10
Hard to Read?
Phone 0161 488 5555 for help
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG
0800 009 2329
http://www.chiesi.uk.com
https://www.chiesimedical.co.uk
+44 (0) 161 488 5555
www.chiesi.uk.com/supply-of-chiesi-products
+44 (0)1748 827 271